These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15731181)

  • 1. Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
    Schilbach K; Kerst G; Walter S; Eyrich M; Wernet D; Handgretinger R; Xie W; Rammensee HG; Müller I; Bühring HJ; Niethammer D
    Blood; 2005 Jul; 106(1):144-9. PubMed ID: 15731181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
    Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
    Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
    Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B; Horn PA; Daubert C; Khattab B; Blasczyk R
    Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Oosten LE; Blokland E; van Halteren AG; Curtsinger J; Mescher MF; Falkenburg JH; Mutis T; Goulmy E
    Blood; 2004 Jul; 104(1):224-6. PubMed ID: 15031203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
    Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
    Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping.
    Verdijk RM; Mutis T; Wilke M; Pool J; Schrama E; Brand A; Goulmy E
    Hematol J; 2002; 3(6):271-5. PubMed ID: 12522448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
    Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
    Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
    Chang J
    Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.
    Cooper LJ; Al-Kadhimi Z; Serrano LM; Pfeiffer T; Olivares S; Castro A; Chang WC; Gonzalez S; Smith D; Forman SJ; Jensen MC
    Blood; 2005 Feb; 105(4):1622-31. PubMed ID: 15507526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
    Front Immunol; 2020; 11():1804. PubMed ID: 32973756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo specific induction of CD8 positive anti-leukemia cytotoxic lymphocytes from umbilical cord blood.
    Tan H; Liu X; Ye X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):129-33. PubMed ID: 17490538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
    Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
    Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA and modified vaccinia Ankara prime-boost vaccination generates strong CD8
    Eldershaw SA; Pearce H; Inman CF; Piper KP; Abbotts B; Stephens C; Nicol S; Croft W; Powell R; Begum J; Taylor G; Nunnick J; Walsh D; Sirovica M; Saddique S; Nagra S; Ferguson P; Moss P; Malladi R
    Br J Haematol; 2021 Nov; 195(3):433-446. PubMed ID: 34046897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
    Kloosterboer FM; van Luxemburg-Heijs SA; van Soest RA; Barbui AM; van Egmond HM; Strijbosch MP; Kester MG; Marijt WA; Goulmy E; Willemze R; Falkenburg JH
    Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
    Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
    Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of donor-derived Wilms tumor antigen 1-specific cytotoxic T lymphocytes with potent anti-leukemia activity for somatic cell therapy in children given haploidentical stem cell transplantation: a feasibility pre-clinical study.
    Ferulli F; Tanzi M; Turin I; Montini E; Rosti V; Acquafredda G; Lisini D; Compagno F; Boghen S; Licari A; Marseglia G; Zecca M; Montagna D
    Cytotherapy; 2019 Sep; 21(9):958-972. PubMed ID: 31279696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.